Open Access
Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases
Jian Guo Chen
1
,
Jian Zhu
1
,
YONG-HUI ZHANG
1
,
Yong-Sheng Chen
1
,
Lu-Lu Ding
1
,
Hai-Zhen Chen
2
,
Ai-Guo Shen
2
,
Gao-Ren Wang
2
Publication type: Journal Article
Publication date: 2021-08-30
scimago Q2
wos Q2
SJR: 0.734
CiteScore: 2.0
Impact factor: 3.4
ISSN: 22535969
PubMed ID:
34513745
General Medicine
Abstract
To explore the long-term trend of liver cancer survival, based on the real-world data (RWD) in the past 45 years from a population-based cancer registry, in Qidong, China.A number of 32,556 patients with liver cancer were registered during the period of 1972 to 2016. Mixed methods by active and passive follow-up were performed. Life table method was employed for survival analysis by SPSS22 software. Wilcoxon (Gehan) statistics was considered as a significant test. Relative survival was calculated by using SURV software, and its annual percent change (APC) was estimated by the Joinpoint Regression Program.The overall observed survival (OS) rates of 1-, 5-, 10-, and 20-year rates from the data series were 18.51%, 6.28%, 4.03%, and 2.84%, and their relative survival (RS) rates were 18.88%, 6.95%, 4.96%, and 4.49%, respectively. For 24,338 male cases, the 5-year OS and RS rates were 5.93% and 6.54%, and for 8218 female cases, 7.34% and 8.15%, respectively, with P values less than 0.01. Survival rates of liver cancer from three 15-year periods of 1972-1986, 1987-2001, and 2002-2016 have increased significantly, with 5-year OS rates of 2.02%, 4.40%, and 10.76%, 5-year RS rates of 2.18%, 4.83%, and 12.18%; 10-year OS and RS rates of 0.95%, 3.00%, and 7.02%, vs 1.13%, 3.65%, and 8.96%, respectively, showing a very significant upward trend (P<0.01). There are significant differences among age groups (P<0.01): those aged 55-64 demonstrated the best OS and RS rates of 5-year, being 8.44% and 9.09%, respectively.There are significant gender and age differences in the survival rate of liver cancer in Qidong. RWD indicates the relative lower survival rate of liver cancer in this area, but great improvement has been achieved over the past decades.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
|
|
|
Frontiers in Oncology
2 publications, 8.7%
|
|
|
Analytical Chemistry
2 publications, 8.7%
|
|
|
Biomedicines
1 publication, 4.35%
|
|
|
Clinics and Research in Hepatology and Gastroenterology
1 publication, 4.35%
|
|
|
Journal of Hepatocellular Carcinoma
1 publication, 4.35%
|
|
|
Russian Journal of Bioorganic Chemistry
1 publication, 4.35%
|
|
|
Investigational New Drugs
1 publication, 4.35%
|
|
|
Translational Oncology
1 publication, 4.35%
|
|
|
Environmental Toxicology
1 publication, 4.35%
|
|
|
Frontiers in Pharmacology
1 publication, 4.35%
|
|
|
Molecules
1 publication, 4.35%
|
|
|
BMC Cancer
1 publication, 4.35%
|
|
|
Cancer Gene Therapy
1 publication, 4.35%
|
|
|
BMC Public Health
1 publication, 4.35%
|
|
|
Computational Biology and Chemistry
1 publication, 4.35%
|
|
|
Breast
1 publication, 4.35%
|
|
|
Journal of the American College of Radiology
1 publication, 4.35%
|
|
|
World Journal of Hepatology
1 publication, 4.35%
|
|
|
In Silico Research in Biomedicine
1 publication, 4.35%
|
|
|
Lecture Notes in Computer Science
1 publication, 4.35%
|
|
|
Journal of Gastrointestinal Oncology
1 publication, 4.35%
|
|
|
1
2
|
Publishers
|
1
2
3
4
5
|
|
|
Elsevier
5 publications, 21.74%
|
|
|
Springer Nature
5 publications, 21.74%
|
|
|
Frontiers Media S.A.
3 publications, 13.04%
|
|
|
MDPI
2 publications, 8.7%
|
|
|
American Chemical Society (ACS)
2 publications, 8.7%
|
|
|
Taylor & Francis
1 publication, 4.35%
|
|
|
Pleiades Publishing
1 publication, 4.35%
|
|
|
Neoplasia Press
1 publication, 4.35%
|
|
|
Wiley
1 publication, 4.35%
|
|
|
Baishideng Publishing Group
1 publication, 4.35%
|
|
|
AME Publishing Company
1 publication, 4.35%
|
|
|
1
2
3
4
5
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
23
Total citations:
23
Citations from 2024:
10
(43.47%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Chen J. G. et al. Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases // Journal of Hepatocellular Carcinoma. 2021. Vol. Volume 8. pp. 1023-1034.
GOST all authors (up to 50)
Copy
Chen J. G., Zhu J., ZHANG Y., Chen Y., Ding L., Chen H., Shen A., Wang G. Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases // Journal of Hepatocellular Carcinoma. 2021. Vol. Volume 8. pp. 1023-1034.
Cite this
RIS
Copy
TY - JOUR
DO - 10.2147/jhc.s321346
UR - https://doi.org/10.2147/jhc.s321346
TI - Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases
T2 - Journal of Hepatocellular Carcinoma
AU - Chen, Jian Guo
AU - Zhu, Jian
AU - ZHANG, YONG-HUI
AU - Chen, Yong-Sheng
AU - Ding, Lu-Lu
AU - Chen, Hai-Zhen
AU - Shen, Ai-Guo
AU - Wang, Gao-Ren
PY - 2021
DA - 2021/08/30
PB - Taylor & Francis
SP - 1023-1034
VL - Volume 8
PMID - 34513745
SN - 2253-5969
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Chen,
author = {Jian Guo Chen and Jian Zhu and YONG-HUI ZHANG and Yong-Sheng Chen and Lu-Lu Ding and Hai-Zhen Chen and Ai-Guo Shen and Gao-Ren Wang},
title = {Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases},
journal = {Journal of Hepatocellular Carcinoma},
year = {2021},
volume = {Volume 8},
publisher = {Taylor & Francis},
month = {aug},
url = {https://doi.org/10.2147/jhc.s321346},
pages = {1023--1034},
doi = {10.2147/jhc.s321346}
}